Olaparib, a breast cancer drug lacking the side effects of chemotherapy, can target an Achilles heel in prostate cancers with a weakness in their ability to repair damaged DNA, revealed clinical trial results.
from Medindia Health News https://ift.tt/3bNpVEF
No comments:
Post a Comment